Sarepta stock took another dive Monday after the biotech company refused the FDA's request to voluntarily stop all shipments ...

And even after the significant gains it has experienced in recent years, it might still be early enough to get on the ...

Investors who bought WeBull (BULL) before last week gained 33.6%. However, after the market closed on Friday, July 18, the ...

Also on Friday, the Food and Drug Administration informally requested that Sarepta voluntarily pause shipments of another gene therapy, Elevidys, which is approved to treat a different type of ...

Every so often, activist investors swarm around underperforming companies in a certain industry and pressure them to change ...

Sunil Chari, Co-founder and MD of Rossari Biotech, said that although the April–June quarter is typically a quiet period, the ...

Biotech company CRISPR Therapeutics has a market cap of around $5 billion, but it has the potential to be much more valuable ...

Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights ...

Stocks like Reliance Industries, HDFC Bank, ICICI Bank, JSW Steel, IDFC First Bank, Dr Reddy's Laboratories, IRCON International, Sona BLW Precision Forgings, Anthem Biosciences, and Spunweb Nonwoven ...